- Home
- AVT vs VKTX Comparison
AVT vs VKTX Comparison
Compare AVT & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVT
- VKTX
- Stock Information
- Founded
- AVT 1921
- VKTX 2012
- Country
- AVT United States
- VKTX United States
- Employees
- AVT N/A
- VKTX N/A
- Industry
- AVT Electronic Components
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- AVT Technology
- VKTX Health Care
- Exchange
- AVT Nasdaq
- VKTX Nasdaq
- Market Cap
- AVT 4.3B
- VKTX 3.8B
- IPO Year
- AVT N/A
- VKTX 2015
- Fundamental
- Price
- AVT $48.45
- VKTX $38.08
- Analyst Decision
- AVT Sell
- VKTX Strong Buy
- Analyst Count
- AVT 3
- VKTX 14
- Target Price
- AVT $49.33
- VKTX $87.00
- AVG Volume (30 Days)
- AVT 889.5K
- VKTX 4.9M
- Earning Date
- AVT 10-29-2025
- VKTX 10-22-2025
- Dividend Yield
- AVT 2.72%
- VKTX N/A
- EPS Growth
- AVT N/A
- VKTX N/A
- EPS
- AVT 2.70
- VKTX N/A
- Revenue
- AVT $22,495,174,000.00
- VKTX N/A
- Revenue This Year
- AVT $5.60
- VKTX N/A
- Revenue Next Year
- AVT $5.99
- VKTX N/A
- P/E Ratio
- AVT $17.93
- VKTX N/A
- Revenue Growth
- AVT N/A
- VKTX N/A
- 52 Week Low
- AVT $39.22
- VKTX $18.92
- 52 Week High
- AVT $57.68
- VKTX $79.10
- Technical
- Relative Strength Index (RSI)
- AVT 34.74
- VKTX 66.57
- Support Level
- AVT $46.73
- VKTX $33.00
- Resistance Level
- AVT $52.81
- VKTX $39.57
- Average True Range (ATR)
- AVT 1.39
- VKTX 2.09
- MACD
- AVT -0.35
- VKTX 0.31
- Stochastic Oscillator
- AVT 25.74
- VKTX 82.90
About AVT Avnet Inc.
Avnet Inc is an electronic component technology distributor and solutions provider. It serves customers from startups and mid-sized businesses to enterprise-level original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, and original design manufacturers (ODMs). The group operates in the Electronic Components segment and supports high and medium-volume customers to markets, sells, and distributes electronic components, and the Farnell segment supports lower-volume customers that need electronic components quickly to develop, prototype, and test their products. Its geographic regions are the Americas, EMEA, and Asia.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.